Inluriyo Tablet, Film Coated
Product Images NDC 0002-1717

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Inluriyo (NDC 0002-1717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label – Inluriyo 200 mg 56 Count Bottle (Inluriyo 200mg Label 56ct 2397)

This is a description of a medication labeled as "Inluriyo" (imlunestrant) in the form of tablets of 200 mg strength. It contains 6 tablets in total. The label instructs not to use if the inner seal is missing or broken. The storage temperature range is specified as 20°C to 25°C (66°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). The dosage details are mentioned to be referred from the Prescribing Information.*

FDA Label Image

Chemical Structure (Inluriyo Uspi Chem V1)

FDA Label Image

Figure 1 (Inluriyo Uspi Fig1 V1)

This text appears to show a progression-free survival (%) graph comparing Fulvestrant and Exemestane over a period of 30 months. The graph displays the percentage of patients with progression-free survival over time with numbers at risk indicated at various time points. This data may be used to analyze the efficacy of these treatments in relation to progression-free survival.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.